The South African Health Products Regulatory Authority has issued a nationwide recall of certain Citro-Soda products after identifying potential contamination risks during inspections at a manufacturing facility in Johannesburg.
According to the regulator, the recall applies specifically to Citro-Soda batches with numbers beginning with the letter “C”. These products were manufactured at the Adcock Ingram facility in Clayville. SAHPRA has clarified that all other batches produced outside this site are considered safe for consumption.
Citro-Soda is a widely used over-the-counter remedy known for treating conditions such as heartburn, stomach acidity, and urinary tract discomfort. Its accessibility and popularity mean the recall has raised concern among consumers, particularly as the affected products may still be available on retail shelves.
The recall follows the discovery of foreign particles in the product during a regulatory inspection. Officials reported finding black fragments and metal particles, which are believed to have originated from worn manufacturing equipment, including conveyor belts and production vessels. Health authorities have warned that ingesting such contaminants could pose serious health risks.

SAHPRA officials emphasised that the recall is a precautionary measure to protect public health. They have urged consumers to carefully check batch numbers before purchasing or using Citro-Soda products. Any product with a batch number starting with “C” should not be consumed and should be returned to the point of purchase where possible.
The regulator has also called on the public to remain vigilant and report any suspected defects in health products. This forms part of broader efforts to strengthen post-market surveillance and ensure that medicines and consumer health products meet strict safety standards.

Consumers are advised to exercise caution, especially as some of the affected stock may still be circulating in stores across the country. The recall highlights the importance of regulatory oversight in safeguarding public health and ensuring that manufacturing processes comply with quality standards.
SAHPRA has indicated that investigations into the source of the contamination are ongoing, and further updates will be provided if necessary.